Lifeward Ltd. Files Proxy Materials
Ticker: LFWD · Form: DEFA14A · Filed: Dec 27, 2024 · CIK: 1607962
Sentiment: neutral
Topics: proxy-statement, shareholder-meeting, corporate-governance
TL;DR
Lifeward Ltd. (fka ReWalk) dropped proxy docs, shareholder meeting incoming.
AI Summary
Lifeward Ltd. (formerly ReWalk Robotics Ltd.) filed a Definitive Additional Materials proxy statement on December 27, 2024. This filing relates to the company's solicitation of proxies for its upcoming shareholder meeting. The company is headquartered at 200 Donald Lynch Blvd., Marlborough, MA.
Why It Matters
This filing indicates that Lifeward Ltd. is actively engaging with its shareholders regarding corporate governance and upcoming decisions, which is a standard but important part of public company operations.
Risk Assessment
Risk Level: low — This is a routine proxy filing, not indicating any immediate financial or operational risks.
Key Players & Entities
- Lifeward Ltd. (company) — Filer of the proxy statement
- ReWalk Robotics Ltd. (company) — Former name of Lifeward Ltd.
- Argo Medical Technologies Ltd. (company) — Earlier former name of Lifeward Ltd.
- 200 Donald Lynch Blvd., Marlborough, MA (company) — Business and mail address
FAQ
What is the purpose of this DEFA14A filing?
This filing is a Definitive Additional Materials proxy statement, used by Lifeward Ltd. to solicit proxies from its shareholders for an upcoming meeting.
When was this filing made?
The filing was made on December 27, 2024.
What is Lifeward Ltd.'s business address?
Lifeward Ltd.'s business address is 200 Donald Lynch Blvd., Marlborough, MA 01752.
Has Lifeward Ltd. always been known by this name?
No, Lifeward Ltd. was formerly known as ReWalk Robotics Ltd. (since 20140620) and prior to that, Argo Medical Technologies Ltd. (since 20140513).
What is the SIC code for Lifeward Ltd.?
The Standard Industrial Classification (SIC) code for Lifeward Ltd. is 3842, which corresponds to ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES.
Filing Stats: 917 words · 4 min read · ~3 pages · Grade level 13.1 · Accepted 2024-12-27 17:14:22
Filing Documents
- zk2432497.htm (DEFA14A) — 13KB
- image00001.jpg (GRAPHIC) — 4KB
- 0001178913-24-004062.txt ( ) — 20KB
Forward-Looking Statements
Forward-Looking Statements In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "should," "would," "seek" and similar terms or phrases. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from the Company's current expectations. These and other risks are more fully discussed in the Company's periodic filings with the SEC, including the risk factors described under the heading "Risk Factors" in the Company's annual report on Form 10-K and 10-K/A for the year ended December 31, 2023 filed with the SEC and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company's actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, Lifeward undertakes no obligation to publicly update any
forward-looking statements, whether as a result of new information, future developments or otherwise
forward-looking statements, whether as a result of new information, future developments or otherwise.